Inova Strategic Investments
VC Fund
Falls Church, United States
Inova Strategic Investments is a VC fund in Falls Church focused on Medical and Health Diagnostics. Inova is Northern Virginia’s leading nonprofit healthcare provider, employing more than 18,000 team members and serving more than 2 million individuals annually through an integrated network of hospitals, primary and specialty care practices, emergency, and urgent care centers, outpatient services and destination institutes such as the Inova Heartand Vascular Institute, Inova Schar Cancer Institute and Inova Neuroscience and Spine Institute. Our mission is to provide world-class healthcare – every time, every touch – to each person in every community we have the privilege to serve. Founded in 1956 as the Fairfax Hospital Association, Inova has grown with its surrounding community and the region to provide a full spectrum of health services, including Northern Virginia’s only Level 1 Trauma Center and Level 4 Neonatal Intensive Care Unit. Its hospitals have a total of 1,800 licensed beds.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Inova Strategic Investments invests in
Stages Inova Strategic Investments invests in
Countries Inova Strategic Investments invests in
Investment Focus
Industry
- Medical 2 (100%)
- Health Diagnostics 2 (100%)
- Genetics 1 (50%)
- Analytics 1 (50%)
- Health Care 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Renovia
|
Renovia is a women-led developer of prescription digital therapeutics, dedicated to improving the lives of women with urinary incontinence and other pelvic floor disorders. The company's technology enables non-invasive, drug-free treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, whilemonitoring usage and progress. It supplements its technology with adherence coaching from the Renovia Women’s Center as well as symptom and adherence reporting to prescribers. | $32.3M / Series B / Aug 21, 2018 | |
Personal Genome Diagnostics
|
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basisof human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States. | $75M / Series B / Jan 04, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Inova Strategic Investments invest in?
Inova Strategic Investments invests primarily in Medical, Health Diagnostics and Genetics startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Inova Strategic Investments last invest?
The most recent investment recorded for Inova Strategic Investments closed in Aug 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
